Klaria Pharma Holding AB (publ) ("Klaria" or the "Company") announces that the Company has signed a license agreement for Sumatriptan Alginate Film (the "Product"), a pharmaceutical product based on K ...
The NICE recommendation of Vyepti as a comparator to other treatments in the CGRP inhibitor class provides another option for people living with episodic or chronic migraine, particularly those ...